Mei-Shu Lai
Director/Board Member at MJ Life Enterprises Sdn. Bhd.
Mei-Shu Lai active positions
Companies | Position | Start | End |
---|---|---|---|
National Taiwan University | Corporate Officer/Principal | 2001-08-31 | - |
MJ Life Enterprises Sdn. Bhd. | Director/Board Member | - | - |
Career history of Mei-Shu Lai
Former positions of Mei-Shu Lai
Companies | Position | Start | End |
---|---|---|---|
ASLAN PHARMACEUTICALS LIMITED | Director/Board Member | 2016-03-31 | 2018-10-29 |
Independent Dir/Board Member | 2016-03-31 | 2018-10-29 | |
Bureau of National Health Insurance | Chief Executive Officer | 1997-12-31 | 2000-12-31 |
President | 1997-12-31 | 2000-12-31 | |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Director/Board Member | - | - |
Training of Mei-Shu Lai
National Taiwan University | Doctorate Degree |
University of Pittsburgh | Graduate Degree |
Statistics
International
Singapore | 3 |
Taiwan | 3 |
United States | 2 |
Operational
Director/Board Member | 3 |
Independent Dir/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ASLAN PHARMACEUTICALS LIMITED | Health Technology |
Private companies | 3 |
---|---|
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Bureau of National Health Insurance | |
MJ Life Enterprises Sdn. Bhd. |
- Stock Market
- Insiders
- Mei-Shu Lai
- Experience